Works matching IS 03618609 AND DT 2024 AND VI 99 AND IP 9

Results: 23
    1
    2
    3
    4

    Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1845, doi. 10.1002/ajh.27421
    By:
    • Pérez Carretero, Claudia;
    • González, Teresa;
    • Quijada Álamo, Miguel;
    • Rigolin, Gian Matteo;
    • Dubuc, Adrian;
    • Villaverde Ramiro, Ángela;
    • Rodríguez‐Sánchez, Alberto;
    • Rubio, Araceli;
    • Dávila, Julio;
    • Vidal, Mª. Jesús;
    • González Gascón y Marín, Isabel;
    • Hernández‐Rivas, José‐Ángel;
    • Benito, Rocío;
    • Volpe, Virginia;
    • Davids, Matthew S.;
    • Abramson, Jeremy S.;
    • Cuneo, Antonio;
    • Dal Cin, Paola;
    • Rodríguez‐Vicente, Ana‐Eugenia;
    • Hernández‐Rivas, Jesús‐María
    Publication type:
    Article
    5

    Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1757, doi. 10.1002/ajh.27413
    By:
    • Scheinberg, Phillip;
    • Clé, Diego Villa;
    • Kim, Jin Seok;
    • Nur, Erfan;
    • Yenerel, Mustafa N.;
    • Barcellini, Wilma;
    • Bonito, Debora;
    • Giai, Valentina;
    • Hus, Marek;
    • Lee, YooJin;
    • Lekue, Cristina Barrenetxea;
    • Panse, Jens;
    • Ueda, Yasutaka;
    • Buatois, Simon;
    • Gentile, Brittany;
    • Kiialainen, Anna;
    • Patel, Himika;
    • Sreckovic, Sasha;
    • Uguen, Marianne;
    • Edwards, John
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1768, doi. 10.1002/ajh.27412
    By:
    • Röth, Alexander;
    • He, Guangsheng;
    • Tong, Hongyan;
    • Lin, Zenghua;
    • Wang, Xiaoqin;
    • Chai‐Adisaksopha, Chatree;
    • Lee, Je‐Hwan;
    • Brodsky, Andres;
    • Hantaweepant, Chattree;
    • Dumagay, Teresita E.;
    • Demichelis‐Gómez, Roberta;
    • Rojnuckarin, Ponlapat;
    • Sun, Jing;
    • Höglund, Martin;
    • Jang, Jun Ho;
    • Gaya, Anna;
    • Silva, Fernando;
    • Obara, Naoshi;
    • Kelly, Richard J.;
    • Beveridge, Leigh
    Publication type:
    Article
    12

    Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1680, doi. 10.1002/ajh.27378
    By:
    • Othman, Tamer;
    • Koller, Paul;
    • Tsai, Ni‐Chun;
    • Yang, Dongyun;
    • Pourhassan, Hoda;
    • Agrawal, Vaibhav;
    • Ngo, Dat;
    • Chen, Jason;
    • Farol, Leonardo;
    • Spielberger, Ricardo;
    • Sahebi, Firoozeh;
    • Al Malki, Monzr M.;
    • Cai, Ji‐Lian;
    • Sandhu, Karamjeet S.;
    • Mansour, Joshua;
    • Salhotra, Amandeep;
    • Ali, Haris;
    • Aribi, Ahmed;
    • Arslan, Shukaib;
    • Marcucci, Guido
    Publication type:
    Article
    13

    Targeting anemia in myeloid neoplasms.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1663, doi. 10.1002/ajh.27408
    By:
    • Gangat, Naseema;
    • Tefferi, Ayalew
    Publication type:
    Article
    14
    15

    Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1746, doi. 10.1002/ajh.27382
    By:
    • Delimpasi, Sosana;
    • Dimopoulos, Meletios A.;
    • Straub, Jan;
    • Symeonidis, Argiris;
    • Pour, Luděk;
    • Hájek, Roman;
    • Touzeau, Cyrille;
    • Bhanderi, Viralkumar K.;
    • Berdeja, Jesus G.;
    • Pavlíček, Petr;
    • Matous, Jeffrey V.;
    • Robak, Pawel J.;
    • Suryanarayan, Kaveri;
    • Miller, Alison;
    • Villarreal, Miguel;
    • Cherepanov, Dasha;
    • Srimani, Jaydeep K.;
    • Yao, Huilan;
    • Labotka, Richard;
    • Orlowski, Robert Z.
    Publication type:
    Article
    16
    17
    18

    Molecular landscape of mature B‐cell lymphoproliferative disorders with BCL3‐translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1830, doi. 10.1002/ajh.27384
    By:
    • Véronèse, Lauren;
    • Bensaber, Hedi;
    • Dannus, Louis‐Thomas;
    • Giannone, Gaetan;
    • Choiset, Christopher;
    • Grimpret, Corentin;
    • Abermil, Nassera;
    • Balducci, Estelle;
    • Bidet, Audrey;
    • Chapiro, Elise;
    • Couronné, Lucile;
    • Daudignon, Agnès;
    • Douet‐Gilbert, Nathalie;
    • Eclache, Virginie;
    • Gaillard, Baptiste;
    • Gaillard, Jean‐Baptiste;
    • Hsoumi, Faten;
    • Lefebvre, Christine;
    • Nadal, Nathalie;
    • Mozziconacci, Marie‐Joelle
    Publication type:
    Article
    19

    Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1732, doi. 10.1002/ajh.27383
    By:
    • Nagler, Arnon;
    • Ngoya, Maud;
    • Galimard, Jacques‐Emmanuel;
    • Labopin, Myriam;
    • Blau, Igor Wolfgang;
    • Kröger, Nicolaus;
    • Gedde‐Dahl, Tobias;
    • Schroeder, Thomas;
    • Burns, David;
    • Salmenniemi, Urpu;
    • Rambaldi, Alessandro;
    • Choi, Goda;
    • Peffault de Latour, Régis;
    • Vydra, Jan;
    • Sengeloev, Henrik;
    • Eder, Matthias;
    • Mielke, Stephan;
    • Forcade, Edouard;
    • Kulagin, Alexander;
    • Ciceri, Fabio
    Publication type:
    Article
    20

    Comparative histological analysis of spleens in pediatric patients with hemolytic anemias: Insights into the pathophysiological mechanisms of spleen destruction in sickle cell anemia.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1670, doi. 10.1002/ajh.27374
    By:
    • Brousse, Valentine;
    • El Hoss, Sara;
    • Isnard, Pierre;
    • Laurance, Sandrine;
    • Lambert, Camille;
    • Ali, Liza;
    • Bonnard, Arnaud;
    • Capito, Carmen;
    • Sarnacki, Sabine;
    • Berrebi, D.;
    • Koehl, Berengère;
    • Benkerrou, Malika;
    • Missud, Florence;
    • Holvoet, Laurent;
    • Ithier, Ghislaine;
    • de Montalembert, Mariane;
    • Allali, Slimane;
    • Tshilolo, Leon;
    • Diebold, Jacques;
    • Molina, Thierry Jo
    Publication type:
    Article
    21
    22

    The prognostic value of blood cellular indices in pulmonary embolism.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1704, doi. 10.1002/ajh.27379
    By:
    • Siddiqui, Fakiha;
    • Tafur, Alfonso;
    • Hussain, Mushtaq;
    • García‐Ortega, Alberto;
    • Darki, Amir;
    • Fareed, Jawed;
    • Jiménez, David;
    • Bikdeli, Behnood;
    • Galeano‐Valle, Francisco;
    • Fernández‐Reyes, José Luis;
    • Pérez‐Pinar, Montserrat;
    • Monreal, Manuel;
    • Adarraga, MD;
    • Alberich‐Conesa, A;
    • Aibar, J;
    • Alda‐Lozano, A;
    • Alfonso, J;
    • Amado, C;
    • Angelina‐García, M;
    • Arcelus, JI
    Publication type:
    Article
    23

    Issue Information.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1661, doi. 10.1002/ajh.26979
    Publication type:
    Article